Shanghai and Shenzhen A Shrs Midday Down 0.4% to 2.3%; Banks and Pharma Stocks Buck TrendAASTOCKS News·Jun 22 at 11:10 PM399001+0.87%000001+0.08%
Shandong Xinhua Pharma wins China approval to start LXH-2103 pain drug clinical trialsPUBT·Jun 22 at 03:37 AM000756-6.14%00719-3.40%
Xinhua Pharmaceutical Wins NMPA Approval for New Electrolyte InjectionTip Ranks·Apr 7 at 06:23 AM512290-2.52%159506-2.01%
Shandong Xinhua Pharmaceutical Wins Approval to Take Over Ezetimibe Marketing RightsTip Ranks·Mar 16 at 05:17 AM513120-1.56%159570-2.12%
U.S. President Trump claimed that tariffs have already affected NOVARTIS AG. The company plans to build a factory in the United StatesWallstreetcn·Feb 27 at 12:31 PMBBH-2.83%NVS-2.54%
After boost from viral dance challenge, Chinese medicine firm’s shares languishSCMP·Feb 22 at 02:20 AM589720-3.69%159316-1.92%
Shandong Xinhua Pharmaceutical Wins NMPA Approval for Phloroglucinol InjectionTip Ranks·Dec 29, 2025 at 03:09 AM000756-6.14%00719-3.40%
